10 research outputs found

    ATMIN is a transcriptional regulator of both lung morphogenesis and ciliogenesis

    Get PDF
    Initially identified in DNA damage repair, ATM-interactor (ATMIN) further functions as a transcriptional regulator of lung morphogenesis. Here we analyse three mouse mutants, Atmin(gpg6/gpg6), Atmin(H210Q/H210Q) and Dynll1(GT/GT), revealing how ATMIN and its transcriptional target dynein light chain LC8-type 1 (DYNLL1) are required for normal lung morphogenesis and ciliogenesis. Expression screening of ciliogenic genes confirmed Dynll1 to be controlled by ATMIN and further revealed moderately altered expression of known intraflagellar transport (IFT) protein-encoding loci in Atmin mutant embryos. Significantly, Dynll1(GT/GT) embryonic cilia exhibited shortening and bulging, highly similar to the characterised retrograde IFT phenotype of Dync2h1. Depletion of ATMIN or DYNLL1 in cultured cells recapitulated the in vivo ciliogenesis phenotypes and expression of DYNLL1 or the related DYNLL2 rescued the effects of loss of ATMIN, demonstrating that ATMIN primarily promotes ciliogenesis by regulating Dynll1 expression. Furthermore, DYNLL1 as well as DYNLL2 localised to cilia in puncta, consistent with IFT particles, and physically interacted with WDR34, a mammalian homologue of the Chlamydomonas cytoplasmic dynein 2 intermediate chain that also localised to the cilium. This study extends the established Atmin-Dynll1 relationship into a developmental and a ciliary context, uncovering a novel series of interactions between DYNLL1, WDR34 and ATMIN. This identifies potential novel components of cytoplasmic dynein 2 and furthermore provides fresh insights into the molecular pathogenesis of human skeletal ciliopathie

    Evaluating the long-term outcomes of periodontal surgery vs. non-surgical treatment in aggressive periodontitis

    No full text
    Background: Aggressive periodontitis is a severe form of periodontal disease characterized by rapid tissue destruction and tooth loss. The optimal treatment approach for managing this condition remains a topic of debate. Materials and Methods: A retrospective cohort study was conducted, involving patients diagnosed with aggressive periodontitis who received either surgical or non-surgical treatment between 2010 and 2020. Clinical and radiographic data were collected at baseline and regular intervals over a 5-year follow-up period. Surgical interventions included flap surgery, guided tissue regeneration, and bone grafting, while non-surgical treatments comprised scaling and root planning with or without adjunctive antibiotics. The primary outcomes assessed included changes in probing depth, clinical attachment level, tooth loss, and patient-reported quality of life measures. Results: A total of 120 patients were included in the study, with 60 patients in each treatment group. The surgical group demonstrated significantly greater reductions in probing depth and gains in clinical attachment level compared to the non-surgical group (P < 0.05). Tooth loss was significantly lower in the surgical group over the 5 years (P < 0.01). Patient-reported outcomes also favored the surgical group, with improved oral health-related quality of life. However, the surgical group had a higher incidence of postoperative complications. Conclusion: This study suggests that periodontal surgery yields superior long-term outcomes in the management of aggressive periodontitis compared to non-surgical treatment

    Phenotyping of <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup> Mutants.

    No full text
    <p>(A) Schematic diagram of PKD1L1 and PKD2 showing protein domains and the nature of the <i>Pkd1l1</i><sup><i>rks</i></sup> and <i>Pkd2</i><sup><i>lrm4</i></sup> point mutations. The double headed red arrow denotes the site of interaction between PKD1L1 and PKD2. PKD—Polycystic Kidney Disease; REJ—Receptor for Egg Jelly; GPS—G-protein Coupled Receptor Proteolytic Site; PLAT—Polycystin-1, Liopoxygenase, Alpha-Toxin. (B) <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup> and sibling control showing reversed and normal situs, respectively. White arrows indicate stomach position. (C) Heart-stomach discordance (H-S Disc.) in <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup>, <i>Dnah11</i><sup><i>iv/iv</i></sup> and <i>Pkd1l1</i><sup><i>rks/rks</i></sup> mutants scored at E13.5. Normally, the heart apex and stomach are positioned to the left. H-S Disc. is defined as the heart apex and stomach being on opposite sides. ns—not significant; *—p<0.05; **—p<0.001, Fisher’s Exact Test applied. (D-F) Lung situs assessed at E13.5 for embryos of the indicated genotypes with the ratio of lung lobes between left and right sides given. The percentage and total numbers of embryos showing each phenotype are indicated in <i>(F)</i>. (G-P) Expression patterns of <i>Nodal</i>, <i>Pitx2</i>, and <i>Lefty1/2</i> in embryos at E8.5 of the indicated genotypes, with the percentage number of embryos exhibiting each phenotype and the total number given. Embryos exhibiting bilateral marker expression are further categorized by whether they show equal or biased expression between the left and right sides. The inset in <i>(M)</i> shows a <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup> embryo with bilateral <i>Pitx2</i> expression but with a right-sided bias. Arrowheads in <i>(N)</i> and <i>(O)</i> indicate midline <i>Lefty1</i> expression. <i>t</i> is shorthand for <i>Pkd1l1</i><sup><i>tm1</i></sup>. (Q-R) Sonic hedgehog (<i>Shh</i>) expression in the node (n) and notochord (nc) at E8.5.</p

    Cilia and PKD2 Localization and Function.

    No full text
    <p>(A-E) PKD2 localization in nodal cilia of embryos of the indicated genotype. Staining was divided into categories and quantitation is given in (<i>A</i>). In <i>(A)</i>, all genotypes are statistically significantly different from each other (p<0.001) except for <i>Pkd2</i><sup><i>+/lrm4</i></sup> and <i>Pkd1l1</i><sup><i>+/tm1</i></sup> which are statistically not significantly different.</p

    Destabilization of a PKD Domain by the <i>Pkd1l1</i><sup><i>rks</i></sup> Mutation.

    No full text
    <p>(A-C) Structure of human PKD1 PKD domain 1 (<i>A</i>) and models of mouse PKD1L1 PKD domain 2; wild-type (<i>B</i>) or <i>rks</i>-mutated (<i>C</i>). Domains are largely composed of β-sheets (block arrows). The aspartic acid mutated in <i>Pkd1l1</i><sup><i>rks</i></sup>, or its equivalent in PKD1, is shown in space-fill. The asterisks denote loss of secondary structure in the <i>rks</i>-mutated domain. (D) SRCD spectroscopy of mouse PKD1L1 PKD domain 2 for wild-type and <i>rks</i>-mutated domains. Spectra are consistent with decreased stability (decreased secondary structure) in mutated domains. (E) Thermal denaturation analysis of PKD1L1 PKD domain 2: a reduced melting temperature (Tm) of 56.4°C is evident in the <i>rks</i>-mutated domain; in wild-type controls a Tm of 68.6°C is detected.</p

    Multi-repression Model for L-R Asymmetry Determination in Crown Cells.

    No full text
    <p>(A) Schematic of a 3 ss flat-mounted mouse embryo showing somites (yellow), and node (blue). (B) Pictorial representation of the multi-repression model in which flow represses <i>Pkd1l1</i> on the left side, resulting in the derepression of <i>Pkd2</i>, inhibition of <i>Cerl2</i> and, as a result, higher NODAL activity on the left. (C-E) Predictions of the multi-repression model in various genetic mutants including the impact on the crown cell genetic pathway as well as the predicted LPM Nodal cascade activity.</p

    Flow-Induced Ca<sup>2+</sup> Signaling Depends on PKD1L1.

    No full text
    <p>(A-B) <i>Pkd1</i><sup><i>+/+</i></sup> <i>(A)</i> and <i>Pkd1</i><sup><i>–/–</i></sup><i>(B)</i> cells were transfected with vector-GFP alone, PKD1L1-GFP or PKD1L1<sup>rks</sup>-GFP. Successfully transfected cells had green fluorescence (GFP), and the entire cell population was observed by DIC. After baseline Ca<sup>2+</sup> level was taken, fluid-shear stress was applied to cells (arrow). Numbers indicate time in seconds (s). Color bars indicate Ca<sup>2+</sup> level (pseudocoloured), where black-purple and yellow-red represent low and high Ca<sup>2+</sup> levels, respectively (C-D) Quantitation from independent experiments of <i>Pkd1</i><sup><i>+/+</i></sup> <i>(C)</i> and <i>Pkd1</i><sup><i>–/–</i></sup><i>(D)</i> cells was averaged and plotted in line graphs. Within the same cell population, successfully transfected (GFP+) and non-transfected (GFP-) cells were analyzed separately. Arrows indicate the start of fluid-shear stress. Time is indicated in seconds (s). (E) Statistical analysis was done by analyzing the peak changes of intracellular Ca<sup>2+</sup>. While vector-GFP is used as a negative control, non-transfected cells (GFP-) were also used as an internal control. n = 150 cells for each group in three independent transfections. *—p<0.05.</p

    The Genetic Relationship between <i>Pkd1l1</i>, <i>Pkd2</i>, and Cilia.

    No full text
    <p>(A-F) <i>Cerl2</i> (<i>A-C</i>) and <i>Nodal</i> (<i>D-F</i>) expression at the node of <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup> and control embryos. Quantitation of <i>in situ</i> signal reveals expression of both genes to be more symmetrical in mutant embryos (<i>C</i>, <i>F</i>). *—p<0.05, unpaired <i>t</i>-test applied. Error bars represent 95% confidence intervals. (G-H) Lung situs <i>(G)</i> (assessed at E13.5) and <i>Pitx2</i> expression <i>(H)</i> (assessed at E8.5) for embryos of the indicated genotypes, with the percentage of embryos exhibiting each phenotype and the total number given.</p

    The Relationship Between Nodal Flow and <i>Pkd1l1/Pkd2</i> Function.

    No full text
    <p>(A-C) Nodal flow in embryos of indicated genotypes was examined at the 1–3 somite stages by means of PIV analysis. Flow was normal in <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup> mutants and wild-type controls but was absent in <i>Dnah11</i><sup><i>iv/iv</i></sup> mutants. Black arrowheads denote the direction and speed of flow at that position while the false coloring indicates the direction and magnitude of the flow. Red indicates leftward and blue rightward fluid movements. (D) Lung situs (assessed at E13.5) and <i>Pitx2</i> expression (assessed at E8.5) for embryos of the indicated genotypes, with the percentage of embryos exhibiting each phenotype and the total number given. (E) <i>Pitx2</i> expression for <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup>, <i>Dnah11</i><sup><i>iv/iv</i></sup> and control embryos for each of the 1–7 somite stages. The onset of <i>Pitx2</i> expression is delayed in <i>Dnah11</i><sup><i>iv/iv</i></sup> mutants but not in <i>Pkd1l1</i><sup><i>tm1/tm1</i></sup> embryos.</p
    corecore